Determining Metabolic Effects of Valproate and Antipsychotic Therapy
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This study will determine the metabolic processes responsible for high levels of blood
glucose, metabolism disorders, and weight gain in people with schizophrenia who have been
treated with antipsychotic medications in combination with valproate.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Mental Health (NIMH) Washington University School of Medicine